Deinove SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Deinove SA Creates Subsidiary for its Antibiotics Program
Deinove SA announced that it has established a dedicated subsidiary, DEINOBIOTICS, to accelerate the development of its antibiotics program. The Company owns 49% of the new entity and holds the right to buy back the outstanding shares.
- Share this
- Digg this